Neuro-Oncology Pioneer Joins CIN
National Brain Tumor Center Established
Dr. Roy Patchell, an internationally known leader in neuro-oncology, has joined CIN as Director of Neuro-Oncology, further elevating the Institute as a national leader in the area of neurosciences.
Dr. Patchell’s research has been instrumental in defining the treatments used for patients with brain and spinal tumors. He joins Dr. Arlan Mintz, Director of Neurosurgical Oncology, as part of the Institute’s National Brain Tumor Center. The center combines their significant experience with advanced technology and dedicated neuroscience resources offered at Capital Health.
“Dr. Patchell’s work has had a tremendous impact on the way brain and spinal tumors are treated,” said Dr. Erol Veznedaroglu, director of the CIN and chairman of the Department of Neurosurgery at Capital Health. “He is a perfect addition to the Institute’s team because I have no doubt his future work will be just as groundbreaking as the research he has already completed. His focus on pushing the boundaries of care forward is at the core of our mission to constantly seek better ways of treating patients with very serious brain and spine diseases.”
Dr. Patchell’s research has been described as ‘transformative,’ and in two groundbreaking studies on brain tumors, he established the standard of care for these patients. In one study, Dr. Patchell and his colleagues conclusively demonstrated the benefits of surgical intervention. In a second study, he demonstrated the benefits of post-operative radiation therapy.
Dr. Patchell has also defined the standard of care for treating spinal cord compression caused by cancer, demonstrating that surgical intervention, followed by radiation, is more effective than radiation alone.
Dr. Patchell joined Capital Health from the Barrow Neurological Institute in Phoenix, Arizona, where he was chairman of the Department of Neurology. Dr. Patchell directed the institute’s Neurology Department, led its neuro-oncology program, and served on its Board of Directors. During his tenure, Dr. Patchell also oversaw the founding and opening of the Muhammad Ali Parkinson’s Center.
“My move to Capital Institute for Neurosciences allows me to be part of something incredibly unique. We are building something that will have a meaningful impact on how we treat patients with brain and spinal tumors,” said Dr. Patchell, who for more than 15 years has been recognized as one of America’s Top Doctors and America’s Top Doctors in Oncology. “The Institute’s core mission of clinical excellence, research, and innovation extends beyond what one usually thinks of in a purely academic, university setting. The Institute does all of those things in a very community-focused, patient-centered way. You do not need to sacrifice personalized care to see the best doctors, and you can see specialists with very significant experience in a more comfortable and convenient setting.”
Over the past several years, Capital Health and its Capital Institute for Neurosciences have become known as a leader in providing the most state-of-the-art, subspecialty care available for complex conditions involving the brain. The number of healthcare facilities and physicians referring patients has grown significantly over the past five years, elevating Capital Health to the leading position in New Jersey for brain and aneurysm surgery. As a result, notable neuroscience experts from renowned programs around the county have chosen to join the Institute’s medical team.
Prior to his tenure at Barrow, Dr. Patchell was the chief of Neuro-Oncology at the University of Kentucky Medical Center. He completed a neurology residency at Johns Hopkins University, a fellowship in neurology at New York Hospital-Cornell Medical Center, and a fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center.
Often invited to lecture around the country and internationally, Dr. Patchell has published extensively, including papers in The New England Journal of Medicine, The Journal of the American Medical Association, and The Lancet, among many others. Dr. Patchell has received substantial research funding from the National Institutes of Health, the National Cancer Institute, and the National Institute of Neurological Disorders and Stroke.